VANDERBILT UNIVERSITY
Attenuation of sepsis-induced microvascular permeability and inflammation with the GLP-1R agonist liraglutide.
Attenuation of sepsis-induced microvascular permeability and inflammation with the GLP-1R agonist liraglutide. is a funding opportunity from VANDERBILT UNIVERSITY, up to 3000, closing May 31, 2028.
May 31, 2028
(670d left)Overview
Project Abstract Sepsis is a critical problem around the world causing 20% of all global deaths. The lack of effective therapeutics leaves critically ill patients with systemic organ dysfunction often caused by damage to the vascular endothelium. The damage induces micro-vessel dysfunction and increased permeability.…